Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribociclib Following Radiation in Pediatric DIPG and HGG
NCT02607124Phase 2Terminated
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Apr 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ribociclib in diffuse intrinsic pontine glioma (DIPG), high-grade glioma (HGG), sponsored by Cincinnati Children's Hospital Medical Center. Started Apr 2016; status: terminated.
02
Drugs
ribociclib
03
Conditions
diffuse intrinsic pontine glioma (DIPG)high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT02607124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607124.